Point72 Asset Management, L.P. 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 22 0.100% | -10,609,978 (-100.00%) | Filing |
| 2022-02-14 4:50 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 10,610,000 9.100% | 3,710,331 (+53.78%) | Filing |
| 2021-03-01 5:19 pm Purchase | 2021-02-17 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 6,899,669 6.400% | 6,899,669 (New Position) | Filing |